Autres langues Stemtech Corporation

Actions

STEK

US85859W1027

Produits pharmaceutiques

Marché Fermé - OTC Markets 20:46:50 11/09/2026			Varia. 5j.	Varia. 1 janv.
0,000100 ^USD	0,00 %		+9 900,00 %	-87,50 %

14/08	Stemtech Corporation publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
22/06	Stemtech Corporation publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

20/08	Stemtech Corporation Appoints Alejandro Carrillio President, Latin Markets
14/08	Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
01/07	Stemtech Corporation Declares July 2026 "Cellular Health Awareness Month"
22/06	Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026
29/05	Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2025
29/05	Stemtech Corporation Auditor Raises 'Going Concern' Doubt
07/04	Stemtech Secures Inventory Funding
18/03	Stemtech Revolution 2026: A Bold New Era In Global Wellness
06/01	Stemtech Corporation Appoints Dr. Lizette Leos, MD as Chief Scientific Officer
19/11	Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
19/08/25	Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
17/07/25	Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025
30/06/25	Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2024
30/06/25	Stemtech Corporation Auditor Raises 'Going Concern' Doubt
05/06/25	Raytelligence publishes report for the first quarter 2025
14/04/25	Stemtech Corporation Announces CFO Changes
19/02/25	Stemtech Corporation, Leading the Global Wellness, Anti-Aging Healthy Revolution
09/01/25	Raytelligence mission from Stemtech Corporation continues
12/12/24	Eevia Board Terminates Process for Reverse Takeover
12/12/24	Stemtech Corporation cancelled the acquisition of Eevia Health Oyj in a reverse merger transaction.
06/12/24	Stemtech : and Seacret Direct / Viago Execute Merger Agreement Form 8 K
02/12/24	Eevia is subject to a possible reverse takeover
02/12/24	Stemtech Corporation signed a letter of intent to acquire Eevia Health Oyj in a reverse merger transaction.
20/11/24	Stemtech Corporation entered into an agreement in principle to acquire SEACRET Direct, LLC for transaction valued at $32.5 million.
19/11/24	Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024